Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00985933 · ClinicalTrials.gov registry record · Early Phase 1

The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers

A Early Phase 1 study of Healthy and Memory Impairment, sponsored by AstraZeneca.

Completed
Registry status
Early Phase 1
Development phase
20
Enrollment target
1
Study location

NCT00985933 is a Early Phase 1 study of Healthy and Memory Impairment that has completed, run by AstraZeneca. The registered enrollment target is 20 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00985933, a Early Phase 1 study of Healthy and Memory Impairment, has completed, sponsored by AstraZeneca.

COMPLETED
Registry status
Early Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess if ketamine will induce, in healthy volunteers, impairment of working memory and if the drug AZD8529 will block the effects of ketamine on working memory as assessed by functional magnetic resonance imaging (fMRI).

Conditions Studied

Healthy Memory Impairment

Interventions

  • DRUG AZD8529
  • DRUG Placebo to match AZD8529

Study Locations (1)

Connecticut

  • Research Site - New Haven

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2010-02
Est. Completion 2011-04
Phase Early Phase 1

Sponsor

AstraZeneca

1,285 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00985933

The ClinicalTrials.gov registry entry for NCT00985933 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which AZD8529 is the first listed.

NCT00985933 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00985933 about?

NCT00985933 is a clinical study titled "The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers". The purpose of this study is to assess if ketamine will induce, in healthy volunteers, impairment of working memory and if the drug AZD8529 will block the effects of ketamine on working memory as assessed by functional magnetic resonance imaging (fMRI).

What is the current status of trial NCT00985933?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2010-02. Estimated completion is 2011-04.

What conditions does trial NCT00985933 study?

This clinical trial studies the following conditions: Healthy, Memory Impairment.

What interventions are being tested in trial NCT00985933?

The interventions under investigation include: AZD8529 (DRUG), Placebo to match AZD8529 (DRUG).

Who is sponsoring clinical trial NCT00985933?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00985933 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Memory Impairment

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.